Prescription drug · NDA AUTHORIZED GENERIC
Methylphenidate Hydrochloride NDC 42858-078
Methylphenidate hydrochloride 30 mg/1 · Capsule, Extended release · Oral · Rhodes Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42858-078-45 | 42858007845 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-078-45)Marketed from Apr 1, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methylphenidate Hydrochloride
- Generic name (nonproprietary)
- methylphenidate hydrochloride
- Active ingredients
- Methylphenidate hydrochloride — 30 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Labeler
- Rhodes Pharmaceuticals LLC
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 205831
- Marketing start
- Listing expires
- DEA schedule
- CII
- Other FDA classes
- Central Nervous System Stimulation (Physiologic effect)
- Identifiers
- Product ID 42858-078_dd7e2d15-d45e-41dc-9d9a-7b68c229b601SPL ID dd7e2d15-d45e-41dc-9d9a-7b68c229b601
- Pharmacologic class
- Central Nervous System Stimulant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442858007845followed by a unit qualifier and the quantityPackage 42858-0078-45. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
Other NDCs under NDA 205831
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Rhodes Pharmaceuticals LLC | 42858-077 |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Rhodes Pharmaceuticals LLC | 42858-075 |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | Rhodes Pharmaceuticals LLC | 42858-076 |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 50 mg/1 | Capsule, Extended releaseOral | Rhodes Pharmaceuticals LLC | 42858-080 |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | Rhodes Pharmaceuticals LLC | 42858-079 |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 60 mg/1 | Capsule, Extended releaseOral | Rhodes Pharmaceuticals LLC | 42858-081 |